N

Neurexis Therapeutics

3 employees

Neurexis Therapeutics develops therapeutic peptide for post-insult neuroprotection.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neuroscience
Health Care
Medical
Life Science

Date founded

2020

Funding rounds raised

Total raised

$900K

from 3 investors over 3 rounds

N

Neurexis Therapeutics raised $900K on April 19, 2023

Investors: National Institute of Neurological Disorders and Stroke (NINDS)

N

Neurexis Therapeutics raised $250K on June 18, 2020

Investors: Colorado Office of Economic Development and International Trade

N

Neurexis Therapeutics raised undisclosed on April 8, 2020

Investors: VIC Technology Venture Development

FAQ